Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179022-15-000078
Filing Date
2015-06-02
Accepted
2015-06-02 17:35:55
Documents
1
Period of Report
2015-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3717
  Complete submission text file 0001179022-15-000078.txt   5193
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 LAKEWAY DRIVE KELLER TX 76248
Business Address
FREEMAN KEVIN D (Reporting) CIK: 0001522478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 15908057